These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32563281)

  • 1. Negative SARS-CoV-2 PCR in patients with chilblain-like lesions.
    Hubiche T; Le Duff F; Chiaverini C; Giordanengo V; Passeron T
    Lancet Infect Dis; 2021 Mar; 21(3):315-316. PubMed ID: 32563281
    [No Abstract]   [Full Text] [Related]  

  • 2. No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains.
    Docampo-Simón A; Sánchez-Pujol MJ; Gimeno-Gascon A; Palazón-Cabanes JC; Juan-Carpena G; Vergara-De Caso E; González-Villanueva I; Blanes-Martínez M; Betlloch-Mas I
    Dermatol Ther; 2020 Nov; 33(6):e14332. PubMed ID: 32975345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAscope in situ hybridization and RT-PCR for detection of SARS-CoV-2 in chilblain-like lesions: A clinical, laboratory and histopathological study.
    Robustelli Test E; Sena P; Locatelli AG; Carugno A; di Mercurio M; Moggio E; Gambini DM; Arosio MEG; Callegaro A; Morotti D; Gianatti A; Vezzoli P
    Pediatr Dermatol; 2022 Jan; 39(1):77-83. PubMed ID: 34989043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic.
    Discepolo V; Catzola A; Pierri L; Mascolo M; Della Casa F; Vastarella M; Smith G; Travaglino A; Punziano A; Nappa P; Staibano S; Bruzzese E; Fabbrocini G; Guarino A; Alessio M
    JAMA Netw Open; 2021 Jun; 4(6):e2111369. PubMed ID: 34110396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
    Hubiche T; Cardot-Leccia N; Le Duff F; Seitz-Polski B; Giordana P; Chiaverini C; Giordanengo V; Gonfrier G; Raimondi V; Bausset O; Adjtoutah Z; Garnier M; Burel-Vandenbos F; Dadone-Montaudié B; Fassbender V; Palladini A; Courjon J; Mondain V; Contenti J; Dellamonica J; Leftheriotis G; Passeron T
    JAMA Dermatol; 2021 Feb; 157(2):202-206. PubMed ID: 33237291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions.
    Brancaccio G; Gussetti N; Sasset L; Alaibac M; Tarantello M; Salmaso R; Trevenzoli M; Cattelan AM
    Pathog Glob Health; 2021; 115(7-8):483-486. PubMed ID: 33729097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2].
    Yatim A; Gilliet M
    Rev Med Suisse; 2021 Mar; 17(732):646-652. PubMed ID: 33793103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report.
    Jamiolkowski D; Mühleisen B; Müller S; Navarini AA; Tzankov A; Roider E
    Lancet; 2020 Aug; 396(10251):598-599. PubMed ID: 32798450
    [No Abstract]   [Full Text] [Related]  

  • 9. Chilblain-like lesions during the COVID-19 pandemic: early or late sign?
    Recalcati S; Fantini F
    Int J Dermatol; 2020 Aug; 59(8):e268-e269. PubMed ID: 32572958
    [No Abstract]   [Full Text] [Related]  

  • 10. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
    Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
    Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 spike protein is present in both endothelial and eccrine cells of a chilblain-like skin lesion.
    Gambichler T; Reuther J; Stücker M; Stranzenbach R; Torres-Reyes C; Schlottmann R; Schmidt WE; Hayajneh R; Sriram A; Becker JC
    J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e187-e189. PubMed ID: 33002210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Chilblain-like lesions on feet and hands during the COVID-19 pandemic.
    El-Azhary R
    Int J Dermatol; 2020 Jun; 59(6):748. PubMed ID: 32383189
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment on: "Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acroischemic lesions".
    Fernandez-Nieto D; Jimenez-Cauhe J; Suarez-Valle A; Moreno-Arrones OM; Saceda-Corralo D; Arana-Raja A; Ortega-Quijano D
    J Am Acad Dermatol; 2020 Sep; 83(3):e233-e234. PubMed ID: 32446824
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to 'No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain'.
    Recalcati S; Tonolo S; Luzzaro F; Fantini F
    Br J Dermatol; 2020 Dec; 183(6):1154-1156. PubMed ID: 32880906
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cutaneous lesions in COVID-19 patients].
    Çiftçi Z; Clabbers JMK; Galimont-Collen AFS; Gostyński A
    Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33332042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to 'No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain'. Reply from the authors.
    Caselli D; Chironna M; Loconsole D; Aricò M
    Br J Dermatol; 2020 Dec; 183(6):1156-1157. PubMed ID: 32974916
    [No Abstract]   [Full Text] [Related]  

  • 17. Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2.
    Lesort C; Kanitakis J; Donzier L; Jullien D
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e630-e632. PubMed ID: 34131969
    [No Abstract]   [Full Text] [Related]  

  • 18. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles.
    Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z
    Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chilblains-like lesions and SARS-CoV-2 in children: An overview in therapeutic approach.
    Pavone P; Marino S; Marino L; Cacciaguerra G; Guarneri C; Nunnari G; Taibi R; Marletta L; Falsaperla R
    Dermatol Ther; 2021 Jan; 34(1):e14502. PubMed ID: 33141476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chilblain-like lesions and COVID-19: second wave, second outbreak.
    Piccolo V; Bassi A; Russo T; Mazzatenta C; Baraldi M; Argenziano G; Neri I; Cutrone M
    J Eur Acad Dermatol Venereol; 2021 May; 35(5):e316-e318. PubMed ID: 33545745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.